1-6 of 6
Ina Bühnen
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Quality of Life with Nivolumab and AVD First-Line Treatment in Hodgkin Lymphoma: Patient-Reported Outcomes from the Phase II GHSG Nivahl Trial

Paul J Bröckelmann, Ina Bühnen, Peter Herhaus, Julia Meissner, Karolin Trautmann-Grill, Horst Müller, Michael Fuchs, Bastian von Tresckow, Peter Borchmann, Andreas Engert, Karolin Behringer
Journal: Blood
Blood (2023) 142 (Supplement 1): 1710.
https://doi.org/10.1182/blood-2023-188734
Published: 2023
Journal Articles

Fertility and Gonadal Function after First-Line Treatment with Nivolumab-AVD in Hodgkin Lymphoma Patients: An Analysis from the Phase II GHSG Nivahl Trial

Paul J Bröckelmann, Ina Bühnen, Peter Herhaus, Julia Meissner, Karolin Trautmann-Grill, Horst Müller, Michael Fuchs, Bastian von Tresckow, Peter Borchmann, Andreas Engert, Karolin Behringer
Journal: Blood
Blood (2023) 142 (Supplement 1): 4456.
https://doi.org/10.1182/blood-2023-189250
Published: 2023
Journal Articles

Interim PET-guided treatment for early-stage NLPHL: a subgroup analysis of the randomized GHSG HD16 and HD17 studies

Clinical Trials & Observations
Dennis A. Eichenauer, Ina Bühnen, Christian Baues, Carsten Kobe, Helen Kaul, Richard Greil, Alden Moccia, Joseé M. Zijlstra, Bernd Hertenstein, Max S. Topp, Marianne Just, Bastian von Tresckow, Hans-Theodor Eich, Michael Fuchs, Markus Dietlein, Sylvia Hartmann, Andreas Engert, Peter Borchmann
Journal: Blood
Blood (2023) 142 (6): 553–560.
https://doi.org/10.1182/blood.2023019939
Published: 2023
Journal Articles

Nivolumab and AVD in Early-Stage Unfavorable Hodgkin Lymphoma: Follow-up Analysis of the Randomized GHSG Phase II Nivahl Trial

Paul J Bröckelmann, Ina Bühnen, Julia Meissner, Karolin Trautmann-Grill, Peter Herhaus, Teresa V Halbsguth, Valdete Schaub, Andrea Kerkhoff, Stephan Mathas, Matthias Bormann, Andreas Dickhut, Helen Kaul, Michael Fuchs, Carsten Kobe, Christian Baues, Peter Borchmann, Andreas Engert, Bastian von Tresckow
Journal: Blood
Blood (2022) 140 (Supplement 1): 1753–1755.
https://doi.org/10.1182/blood-2022-168846
Published: 2022
Journal Articles

Outcomes of Anti-PD1 Treatment for Relapsed/Refractory Hodgkin Lymphoma: A German Hodgkin Study Group (GHSG) Multi-Center Real-World Analysis

Jesko Momotow, Ina Bühnen, Karolin Trautmann-Grill, Guido Kobbe, Martin Wilhelm, Bernhard Heinrich, Tobias Gaska, Helmut Forstbauer, Burkhard Schmidt, Andreas Hüttmann, Gerhard Heil, Doris M. Kraemer, William Hermann Krüger, Vanja Zeremski, Norbert Grobe, Kathleen Jentsch-Ulrich, Michael Fuchs, Bastian von Tresckow, Peter Borchmann, Andreas Engert, Paul J Bröckelmann
Journal: Blood
Blood (2021) 138 (Supplement 1): 4533.
https://doi.org/10.1182/blood-2021-153200
Published: 2021
Journal Articles

Treatment of Early-Stage Nodular Lymphocyte-Predominant Hodgkin Lymphoma: A Subgroup Analysis of the Randomized German Hodgkin Study Group HD16 Study

Dennis A. Eichenauer, Ina Bühnen, Michael Fuchs, Helen Kaul, Carsten Kobe, Sylvia Hartmann, Christian Baues, Bastian von Tresckow, Peter Borchmann, Andreas Engert
Journal: Blood
Blood (2021) 138 (Supplement 1): 2439.
https://doi.org/10.1182/blood-2021-145427
Published: 2021